vs

Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and MidWestOne Financial Group, Inc. (MOFG). Click either name above to swap in a different company.

MidWestOne Financial Group, Inc. is the larger business by last-quarter revenue ($61.3M vs $47.7M, roughly 1.3× IRONWOOD PHARMACEUTICALS INC). MidWestOne Financial Group, Inc. runs the higher net margin — 27.8% vs -4.8%, a 32.5% gap on every dollar of revenue. On growth, MidWestOne Financial Group, Inc. posted the faster year-over-year revenue change (35.9% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $16.7M). Over the past eight quarters, MidWestOne Financial Group, Inc.'s revenue compounded faster (37.2% CAGR vs -20.2%).

Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.

MidWestOne Financial Group, Inc. is a bank holding company headquartered in Iowa City, Iowa. The bank operates 56 branches. It is the 3rd largest bank headquartered in Iowa. It operates in Iowa, Minnesota, Wisconsin, Colorado, and Florida.

IRWD vs MOFG — Head-to-Head

Bigger by revenue
MOFG
MOFG
1.3× larger
MOFG
$61.3M
$47.7M
IRWD
Growing faster (revenue YoY)
MOFG
MOFG
+83.3% gap
MOFG
35.9%
-47.3%
IRWD
Higher net margin
MOFG
MOFG
32.5% more per $
MOFG
27.8%
-4.8%
IRWD
More free cash flow
IRWD
IRWD
$57.8M more FCF
IRWD
$74.6M
$16.7M
MOFG
Faster 2-yr revenue CAGR
MOFG
MOFG
Annualised
MOFG
37.2%
-20.2%
IRWD

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
IRWD
IRWD
MOFG
MOFG
Revenue
$47.7M
$61.3M
Net Profit
$-2.3M
$17.0M
Gross Margin
Operating Margin
14.3%
35.1%
Net Margin
-4.8%
27.8%
Revenue YoY
-47.3%
35.9%
Net Profit YoY
-200.9%
117.8%
EPS (diluted)
$0.01
$0.82

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRWD
IRWD
MOFG
MOFG
Q4 25
$47.7M
Q3 25
$122.1M
$61.3M
Q2 25
$85.2M
$60.2M
Q1 25
$41.1M
$57.6M
Q4 24
$90.5M
$48.9M
Q3 24
$91.6M
$37.5M
Q2 24
$94.4M
$57.9M
Q1 24
$74.9M
$44.5M
Net Profit
IRWD
IRWD
MOFG
MOFG
Q4 25
$-2.3M
Q3 25
$40.1M
$17.0M
Q2 25
$23.6M
$10.0M
Q1 25
$-37.4M
$15.1M
Q4 24
$2.3M
$16.3M
Q3 24
$3.6M
$-95.7M
Q2 24
$-860.0K
$15.8M
Q1 24
$-4.2M
$3.3M
Operating Margin
IRWD
IRWD
MOFG
MOFG
Q4 25
14.3%
Q3 25
61.8%
35.1%
Q2 25
53.2%
20.9%
Q1 25
-70.7%
34.0%
Q4 24
34.8%
43.1%
Q3 24
28.0%
-347.0%
Q2 24
26.5%
36.0%
Q1 24
14.7%
9.5%
Net Margin
IRWD
IRWD
MOFG
MOFG
Q4 25
-4.8%
Q3 25
32.8%
27.8%
Q2 25
27.7%
16.6%
Q1 25
-90.9%
26.3%
Q4 24
2.5%
33.4%
Q3 24
4.0%
-255.1%
Q2 24
-0.9%
27.3%
Q1 24
-5.6%
7.3%
EPS (diluted)
IRWD
IRWD
MOFG
MOFG
Q4 25
$0.01
Q3 25
$0.23
$0.82
Q2 25
$0.14
$0.48
Q1 25
$-0.23
$0.73
Q4 24
$0.03
$1.30
Q3 24
$0.02
$-6.05
Q2 24
$-0.01
$1.00
Q1 24
$-0.03
$0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRWD
IRWD
MOFG
MOFG
Cash + ST InvestmentsLiquidity on hand
$215.5M
Total DebtLower is stronger
$98.0M
Stockholders' EquityBook value
$-261.8M
$606.1M
Total Assets
$396.9M
$6.2B
Debt / EquityLower = less leverage
0.16×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRWD
IRWD
MOFG
MOFG
Q4 25
$215.5M
Q3 25
$140.4M
Q2 25
$92.9M
Q1 25
$108.5M
Q4 24
$88.6M
Q3 24
$88.2M
Q2 24
$105.5M
Q1 24
$121.5M
Total Debt
IRWD
IRWD
MOFG
MOFG
Q4 25
Q3 25
$199.5M
$98.0M
Q2 25
$199.3M
$112.3M
Q1 25
$199.2M
$111.4M
Q4 24
$199.0M
$113.4M
Q3 24
$198.8M
$115.1M
Q2 24
$198.6M
$114.8M
Q1 24
$398.3M
$122.1M
Stockholders' Equity
IRWD
IRWD
MOFG
MOFG
Q4 25
$-261.8M
Q3 25
$-264.2M
$606.1M
Q2 25
$-308.2M
$589.0M
Q1 25
$-334.1M
$579.6M
Q4 24
$-301.3M
$559.7M
Q3 24
$-311.3M
$562.2M
Q2 24
$-321.7M
$543.3M
Q1 24
$-330.5M
$528.0M
Total Assets
IRWD
IRWD
MOFG
MOFG
Q4 25
$396.9M
Q3 25
$396.1M
$6.2B
Q2 25
$342.9M
$6.2B
Q1 25
$327.2M
$6.3B
Q4 24
$350.9M
$6.2B
Q3 24
$389.5M
$6.6B
Q2 24
$395.6M
$6.6B
Q1 24
$438.8M
$6.7B
Debt / Equity
IRWD
IRWD
MOFG
MOFG
Q4 25
Q3 25
0.16×
Q2 25
0.19×
Q1 25
0.19×
Q4 24
0.20×
Q3 24
0.20×
Q2 24
0.21×
Q1 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRWD
IRWD
MOFG
MOFG
Operating Cash FlowLast quarter
$74.6M
$17.7M
Free Cash FlowOCF − Capex
$74.6M
$16.7M
FCF MarginFCF / Revenue
156.3%
27.3%
Capex IntensityCapex / Revenue
0.0%
1.5%
Cash ConversionOCF / Net Profit
1.04×
TTM Free Cash FlowTrailing 4 quarters
$127.0M
$109.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRWD
IRWD
MOFG
MOFG
Q4 25
$74.6M
Q3 25
$47.6M
$17.7M
Q2 25
$-15.1M
$24.9M
Q1 25
$20.0M
$8.7M
Q4 24
$15.2M
$63.2M
Q3 24
$9.9M
$-2.8M
Q2 24
$33.5M
$25.2M
Q1 24
$45.0M
$9.6M
Free Cash Flow
IRWD
IRWD
MOFG
MOFG
Q4 25
$74.6M
Q3 25
$47.6M
$16.7M
Q2 25
$-15.1M
$23.8M
Q1 25
$19.9M
$8.3M
Q4 24
$60.8M
Q3 24
$9.9M
$-3.0M
Q2 24
$33.4M
$24.6M
Q1 24
$44.9M
$9.1M
FCF Margin
IRWD
IRWD
MOFG
MOFG
Q4 25
156.3%
Q3 25
39.0%
27.3%
Q2 25
-17.7%
39.5%
Q1 25
48.4%
14.4%
Q4 24
124.2%
Q3 24
10.8%
-7.9%
Q2 24
35.4%
42.5%
Q1 24
60.0%
20.4%
Capex Intensity
IRWD
IRWD
MOFG
MOFG
Q4 25
0.0%
Q3 25
0.0%
1.5%
Q2 25
0.0%
1.9%
Q1 25
0.1%
0.7%
Q4 24
0.0%
4.9%
Q3 24
0.0%
0.6%
Q2 24
0.1%
1.1%
Q1 24
0.1%
1.2%
Cash Conversion
IRWD
IRWD
MOFG
MOFG
Q4 25
Q3 25
1.19×
1.04×
Q2 25
-0.64×
2.50×
Q1 25
0.57×
Q4 24
6.74×
3.87×
Q3 24
2.71×
Q2 24
1.60×
Q1 24
2.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons